Cargando…

Generic amyloid fibrillation of TMEM106B in patient with Parkinson’s disease dementia and normal elders

Detalles Bibliográficos
Autores principales:	Fan, Yun, Zhao, Qinyue, Xia, Wencheng, Tao, Youqi, Yu, Wenbo, Chen, Mingjia, Liu, Yiqi, Zhao, Jue, Shen, Yan, Sun, Yunpeng, Si, Chenfang, Zhang, Shenqing, Zhang, Yaoyang, Li, Wensheng, Liu, Cong, Wang, Jian, Li, Dan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160068/ https://www.ncbi.nlm.nih.gov/pubmed/35477998 http://dx.doi.org/10.1038/s41422-022-00665-3

Ejemplares similares

Molecular structure of an amyloid fibril formed by FUS low-complexity domain
por: Sun, Yunpeng, et al.
Publicado: (2021)

Identification of TMEM106B amyloid fibrils provides an updated view of TMEM106B biology in health and disease
por: Perneel, Jolien, et al.
Publicado: (2022)

Subtle change of fibrillation condition leads to substantial alteration of recombinant Tau fibril structure
por: Li, Xiang, et al.
Publicado: (2022)

Heparin induces α-synuclein to form new fibril polymorphs with attenuated neuropathology
por: Tao, Youqi, et al.
Publicado: (2022)

Age-dependent formation of TMEM106B amyloid filaments in human brains
por: Schweighauser, Manuel, et al.
Publicado: (2022)

The major TMEM106B dementia risk allele affects TMEM106B protein levels, fibril formation, and myelin lipid homeostasis in the ageing human hippocampus
por: Lee, Jun Yup, et al.
Publicado: (2023)

C-terminal TMEM106B fragments in human brain correlate with disease-associated TMEM106B haplotypes
por: T. Vicente, Cristina, et al.
Publicado: (2023)

TMEM106A transcriptionally regulated by promoter methylation is involved in invasion and metastasis of hepatocellular carcinoma: TMEM106A is involved in invasion and metastasis of HCC
por: Shi, Shiming, et al.
Publicado: (2022)

Antibody-recognizing residues 188-211 of TMEM106B exhibit immunohistochemical reactivity with the TMEM106B C-terminal fragment
por: Ishikawa, Ruoyi, et al.
Publicado: (2023)

Variation in TMEM106B in chronic traumatic encephalopathy
por: Cherry, Jonathan D., et al.
Publicado: (2018)

Lysosomal dysfunction in TMEM106B hypomyelinating leukodystrophy
por: Ito, Yoko, et al.
Publicado: (2018)

The major TMEM106B dementia risk allele affects TMEM106B protein levels and myelin lipid homeostasis in the ageing human hippocampus
por: Lee, Jun Yup, et al.
Publicado: (2023)

TMEM106B expression is reduced in Alzheimer’s disease brains
por: Satoh, Jun-ichi, et al.
Publicado: (2014)

TMEM106C contributes to the malignant characteristics and poor prognosis of hepatocellular carcinoma
por: Duan, Jicheng, et al.
Publicado: (2021)

Immunoprecipitation of Amyloid Fibrils by the Use of an Antibody that Recognizes a Generic Epitope Common to Amyloid Fibrils
por: Greiner, Erin R., et al.
Publicado: (2014)

TMEM106B regulates microglial proliferation and survival in response to demyelination
por: Zhang, Tingting, et al.
Publicado: (2023)

TMEM106A inhibits enveloped virus release from cell surface
por: Mao, Dexin, et al.
Publicado: (2022)

TMEM106B aggregation in neurodegenerative diseases: linking genetics to function
por: Jiao, Hai-Shan, et al.
Publicado: (2023)

Loss of TMEM106B and PGRN leads to severe lysosomal abnormalities and neurodegeneration in mice
por: Feng, Tuancheng, et al.
Publicado: (2020)

TMEM106B a Novel Risk Factor for Frontotemporal Lobar Degeneration
por: van der Zee, Julie, et al.
Publicado: (2011)

Lysosomal TMEM106B interacts with galactosylceramidase to regulate myelin lipid metabolism
por: Takahashi, Hideyuki, et al.
Publicado: (2023)

The identification of high-performing antibodies for transmembrane protein 106B (TMEM106B) for use in Western blot, immunoprecipitation, and immunofluorescence
por: Ayoubi, Riham, et al.
Publicado: (2023)

SARS-CoV-2 impairs the disassembly of stress granules and promotes ALS-associated amyloid aggregation
por: Li, Yichen, et al.
Publicado: (2022)

rs1990622 variant associates with Alzheimer’s disease and regulates TMEM106B expression in human brain tissues
por: Hu, Yang, et al.
Publicado: (2021)

The hereditary mutation G51D unlocks a distinct fibril strain transmissible to wild-type α-synuclein
por: Sun, Yunpeng, et al.
Publicado: (2021)

TMEM106B haplotypes have distinct gene expression patterns in aged brain
por: Ren, Yingxue, et al.
Publicado: (2018)

Partial Tmem106b reduction does not correct abnormalities due to progranulin haploinsufficiency
por: Arrant, Andrew E., et al.
Publicado: (2018)

A novel, potentially targetable TMEM106B-BRAF fusion in pleomorphic xanthoastrocytoma
por: Hsiao, Susan J., et al.
Publicado: (2017)

Loss of Tmem106b leads to cerebellum Purkinje cell death and motor deficits
por: Rademakers, Rosa, et al.
Publicado: (2021)

The nuclear localization sequence mediates hnRNPA1 amyloid fibril formation revealed by cryoEM structure
por: Sun, Yunpeng, et al.
Publicado: (2020)

TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohort
por: van der Zee, Julie, et al.
Publicado: (2011)

Loss of TMEM106B potentiates lysosomal and FTLD‐like pathology in progranulin‐deficient mice
por: Werner, Georg, et al.
Publicado: (2020)

TMEM106B deficiency impairs cerebellar myelination and synaptic integrity with Purkinje cell loss
por: Feng, Tuancheng, et al.
Publicado: (2022)

TMEM106B Acts as a Modifier of Cognitive and Motor Functions in Amyotrophic Lateral Sclerosis
por: Manini, Arianna, et al.
Publicado: (2022)

Looking for a generic inhibitor of amyloid-like fibril formation among flavone derivatives
por: Šneideris, Tomas, et al.
Publicado: (2015)

Expression of TMEM106B, the frontotemporal lobar degeneration-associated protein, in normal and diseased human brain
por: Busch, Johanna I, et al.
Publicado: (2013)

TMEM106B, a risk factor for FTLD and aging, has an intrinsically disordered cytoplasmic domain
por: Kang, Jian, et al.
Publicado: (2018)

LINC00238 inhibits hepatic carcinoma progression by activating TMEM106C-mediated apoptosis pathway
por: Jiang, Caihua, et al.
Publicado: (2021)

Severe Epilepsy and Movement Disorder May Be Early Symptoms of TMEM106B-Related Hypomyelinating Leukodystrophy
por: Solazzi, Roberta, et al.
Publicado: (2022)

Case report: TMEM106B haplotype alters penetrance of GRN mutation in frontotemporal dementia family
por: Perneel, Jolien, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n0f0u4pu72c7pdkeeajof2vqvd